Department of Orthopaedic Surgery, Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Medicina (Kaunas). 2023 Apr 7;59(4):725. doi: 10.3390/medicina59040725.
: The medial collateral ligament (MCL) is one of the major supporting ligaments of the knee joint, and MCL injuries are common where excessive valgus loading is applied to the knee joint. Although most MCL injuries can be treated conservatively, healing of the MCL can take several weeks to months. Furthermore, once injured, the biomechanical properties of the healed MCL differ from those of the native MCL, resulting in an increased risk of re-injury and chronic remnant symptoms. Mesenchymal stem cells (MSCs), owing to their therapeutic potential, have been investigated in various musculoskeletal injuries, and some preclinical studies regarding MSC-based approaches in MCL injuries have shown promising results. Despite satisfactory results in preclinical studies, there is still a lack of clinical studies in the orthopedic literature. This article describes the basic knowledge of the MCL, standard treatments for MCL injuries, and recent studies regarding the application of MSCs for enhanced healing of the MCL. MSC-based approaches are expected to be a potential therapeutic option for enhanced healing of the MCL in the future.
: 内侧副韧带(MCL)是膝关节的主要支持韧带之一,当膝关节受到过度外翻负荷时,MCL 容易受伤。虽然大多数 MCL 损伤可以保守治疗,但 MCL 的愈合可能需要数周或数月的时间。此外,一旦受伤,愈合后的 MCL 的生物力学特性与原生 MCL 不同,导致再次受伤和慢性残留症状的风险增加。间充质干细胞(MSCs)由于其治疗潜力,已在各种肌肉骨骼损伤中进行了研究,一些关于 MSC 治疗 MCL 损伤的临床前研究显示出了有前景的结果。尽管临床前研究结果令人满意,但在骨科文献中仍然缺乏临床研究。本文介绍了 MCL 的基础知识、MCL 损伤的标准治疗方法以及最近关于 MSCs 应用于增强 MCL 愈合的研究。基于 MSC 的方法有望成为未来增强 MCL 愈合的一种潜在治疗选择。